AI tool predicts melanoma survivor's risk of recurrence 

A new AI tool may help clinicians determine which early stage melanoma patients would likely benefit from aggressive treatment even at the onset of the disease.

Related Keywords

Massachusetts , United States , Dana Farber Cancer Institute , Wenxin Chen , Ahmad Rajeh , Noraa Alexander , Kimberly Tang , Genevievem Boland , Yevgeniyr Semenov , Munachimso Amadife , Michaelr Collier , Shijia Zhang , Seok Choi , Stacey Duey , Yining Hua , Department Of Dermatology , Massachusetts General Hospital , Mass General Brigham , Mass General , Min Seok Choi , Jordan Phillips , Artificial Intelligence , Early Stage Melanoma , Melanoma ,